Jane Street
RVPH

Jane Street’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jane Street’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,030
Closed -$28.1K – 12805
2025
Q4 		$28.1K Sell
5,030
-760
-13% -$8.45K ﹤0.01% 10659
2025
Q3 		$42.7K Buy
5,790
+2,795
+93% +$23.8K ﹤0.01% 10389
2025
Q2 		$22.8K Sell
2,995
-510
-15% -$7.94K ﹤0.01% 9342
2025
Q1 		$66.9K Sell
3,505
-2,595
-43% -$81.6K ﹤0.01% 8933
2024
Q4 		$221K Buy
+6,100
New +$170K ﹤0.01% 8249

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's RVPH Position: Q1 2026 in Review

Jane Street sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 44,737 shares — an estimated $250K sold.

Jane Street first reported a position in RVPH in Q3 2022 and held it in 6 quarters. The position peaked at $250K in Q4 2025. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Jane Street reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 44,737 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $250K.
  • Jane Street first reported a position in REVIVA PHARMA HLDGS INC in Q3 2022 and held it in 6 quarters.
  • Jane Street's REVIVA PHARMA HLDGS INC position peaked at $250K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.